跳至主要内容
临床试验/CTRI/2019/11/022134
CTRI/2019/11/022134招募中未知

Therapeutic outcome of intralesional immunotherapy using Measles, Mumps and Rubella vaccine in Molluscum contagiosum: A Randomized, placebo-controlled trial - ILMMR in MC

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically diagnosed patients with multiple ( 2 or more) lesions of Molluscum contagiosum with no history of topical or systemic therapy taken for current lesions and are willing for follow up.

排除标准

  • 1. Patients with a past history of allergic response to MMR or any other vaccine.
  • 2. Patients with acute febrile illness or bacterial infections.
  • 3. Patients with immunosuppression, HIV infection, Hepatitis B or Hepatitis C infection.
  • 4. Patients with only anogenital lesions.
  • 5. Pregnant or lactating women.
  • 6. Patients having a history of asthma, allergic skin disorders or convulsions.

研究者

发起方
I

相似试验